SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001328143-21-000093
Filing Date
2021-11-24
Accepted
2021-11-24 16:10:40
Documents
1
Period of Report
2021-11-24

Document Format Files

Seq Description Document Type Size
1 FORM 4 wf-form4_163778822454298.html 4  
1 FORM 4 wf-form4_163778822454298.xml 4 11720
  Complete submission text file 0001328143-21-000093.txt   13212
Mailing Address 1900 POWELL ST., SUITE 1000 EMERYVILLE CA 94608
Business Address 1900 POWELL ST., SUITE 1000 EMERYVILLE CA 94608 510-450-3554
Adamas Pharmaceuticals Inc (Issuer) CIK: 0001328143 (see all company filings)

IRS No.: 421560076 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences

Mailing Address C/O RETROPHIN, INC. 12255 EL CAMINO REAL, SUITE 250 SAN DIEGO CA 92130
Business Address
McFarlane Neil F. (Reporting) CIK: 0001681098 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-36399 | Film No.: 211446543